D. E. Shaw & Co., Inc. - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$47,824
-81.9%
27,173
-68.3%
0.00%
Q1 2023$263,737
-85.3%
85,629
-74.7%
0.00%
-100.0%
Q4 2022$1,797,341
+160.1%
339,121
+73.1%
0.00%
+100.0%
Q3 2022$691,000195,8840.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$9,254,0002.96%
SECTORAL ASSET MANAGEMENT INC 1,053,779$9,347,0000.80%
Pentwater Capital Management LP 4,879,490$43,281,0000.56%
Vivo Capital, LLC 926,449$8,218,0000.48%
Boxer Capital, LLC 1,251,055$11,097,0000.38%
Ikarian Capital, LLC 228,000$2,022,0000.15%
Perceptive Advisors 787,745$6,987,0000.10%
Rock Springs Capital Management LP 367,499$3,260,0000.08%
PURA VIDA INVESTMENTS, LLC 148,949$1,321,0000.07%
PIPER SANDLER & CO. 8,298$74,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders